NEK6 inhibitor 8 is primarily utilized in the field of cancer research and therapy development. It functions by targeting and inhibiting NEK6, a protein kinase involved in cell cycle regulation, particularly during mitosis. By blocking NEK6 activity, this compound disrupts the proliferation of cancer cells, making it a potential candidate for anticancer drug development. Researchers use it to study the role of NEK6 in tumor growth and to explore its effectiveness in preclinical models of various cancers, such as breast, lung, and colorectal cancer. Additionally, it aids in understanding the molecular mechanisms of cell division and identifying new therapeutic strategies for cancer treatment.